AI-generated analysis. Always verify with the original filing.
AngioDynamics reported a mixed third quarter with revenue growth of 8.9% to $78.4 million, but profitability and cash flow deteriorated as operating and net losses widened significantly, reflecting ongoing operational pressures and restructuring execution.
AngioDynamics delivered revenue of $78.4 million for the third quarter of fiscal 2026, an increase of 8.9% compared to $72.0 million in the prior year period. This growth was primarily driven by positive impacts from sales volume and price, which have been highlighted as key factors influencing gross margin. The company's Med Device revenue also showed growth, supported by increases in Core and Venous product lines, although this was partially offset by softness in other areas such as Ports. Management emphasizes revenue and gross margin as focal points in assessing operating performance, indicating that top-line expansion remains a strategic priority even amid broader challenges.
Despite revenue growth, profitability metrics deteriorated significantly. Gross profit rose 6.7% to $41.5 million, yielding a gross margin of 52.9%, which reflects the beneficial effects of pricing and volume on cost structures. However, operating income declined to a loss of -$13.0 million, a 29.8% worsening from the prior year's loss of -$10.0 million, resulting in an operating margin of -16.5%. This contraction underscores that revenue gains were insufficient to offset rising operational expenses. Net loss deepened to -$8.1 million, an 83.4% increase from -$4.4 million a year ago, and diluted EPS fell to -$0.19 from -$0.11. The CEO uses gross margin in budgeting and forecasting to guide strategic initiatives, but the widening losses suggest that cost management and restructuring efforts are pressuring near-term results.
Cash flow from operations was an outflow of -$14.4 million, an improvement from -$28.9 million in the prior year quarter, yet it remained negative. Capital expenditures were $2.2 million, down from $3.7 million a year ago, contributing to a free cash flow of -$16.5 million. This persistent cash burn highlights liquidity challenges, as management actively evaluates the company's liquidity position and communicates with customers and suppliers to mitigate risks. The current macroeconomic environment, including inflation, supply chain reliability, labor shortages, and tariffs, continues to impact the business and may pose future risks, necessitating careful oversight of financial flexibility.
Operational signals indicate ongoing pressures, such as assumptions about future inventory demand and market value, which affect cost structures and profitability. Transaction prices are typically based on contracted rates, providing some stability but not immune to broader economic fluctuations. Management's commentary stresses a focus on gross margin, operating income, earnings per share, and cash flow from operations when evaluating performance. Restructuring activities are expected to be completed by the end of fiscal 2026, aiming to optimize operations. However, the company faces headwinds from manufacturing capabilities, supply chain disruptions, and inflationary costs, which require continuous assessment to navigate the uncertain landscape ahead.
EPS
$-0.19
Revenue
$78.4M
Net Income
-$8.1M
Gross Margin
52.9%
Gross Profit
$41.5M
free cash flow
-$16.5M
Operating Income
-$13.0M
operating margin
-16.5%